COMMUNIQUÉS West-GlobeNewswire

Aptinyx Presents Data Demonstrating Positive Activity of NYX-458 on Cognitive Performance and Biomarkers in a Preclinical Model of Head Injury
21/08/2019
EVANSTON, Ill., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Invitation to Q2 conference call
21/08/2019
Oslo, Norway, 21 August 2019 Vistin Pharma ASA will release its second quarter 2019 results on Thursday 29 August, 2019. Vistin Pharma will host a conference call for all shareholders and interested parties on 29 August [...]
Assure Holdings to Present at the 8th Annual Gateway Conference on September 4th
21/08/2019
DENVER, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has been invited to present at the 8 th [...]
SPR Therapeutics’ SPRINT Peripheral Nerve Stimulation System Significantly Reduces Opioid Use in Patients with Low Back Pain, Interim Data Show
21/08/2019
Majority of patients treated with SPRINT 60-day PNS therapy also achieved clinically significant reductions in pain intensity, disability and pain interference CLEVELAND, Ohio and KISSIMMEE, Florida, Aug. 21, 2019 ( [...]
Shockwave Medical to Participate in Upcoming Investor Conferences
21/08/2019
SANTA CLARA, Calif. , Aug. 21, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]
MyoKardia Begins Dosing in Phase 1 Clinical Study of MYK-224 for Hypertrophic Cardiomyopathy
21/08/2019
Topline Results Expected in Mid-2020 SOUTH SAN FRANCISCO, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced that it has dosed the first subjects in a Phase 1 clinical study of MYK- [...]
Golden Leaf Holdings to Report Fiscal Second Quarter Earnings
21/08/2019
TORONTO, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]
SHINKEI Therapeutics Announces Investigational New Drug Application Submission for MR-201, a Novel Dosage Form for Treatment of Pseudobulbar Affect
21/08/2019
PRINCETON, N.J., Aug. 21, 2019 (GLOBE NEWSWIRE) -- SHINKEI Therapeutics, a clinical stage pharmaceutical company focused on the development of drugs for the treatment of Central Nervous System (CNS) disorders, today [...]
Republic of Colombia’s food and drug regulatory agency grants clearance for Biomerica’s colorectal cancer screening test to be sold in Colombia
21/08/2019
Biomerica also adds new director of sales and marketing for Europe and South America IRVINE, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced the Republic of Colombia Ministry of Health [...]
Pre-Clinical Evidence Confirms Veyonda® Abscopal Effect
21/08/2019
Veyonda ® is being developed as a transformative anti-cancer treatment (DARRT) in combination with radiotherapy to produce off-target responses known as an abscopal effect Pre-clinical studies now confirming this effect [...]
Progressive Care Inc. Reports Record Revenue of $3.4 Million for July 2019
21/08/2019
MIAMI, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced record revenues of approximately $3.4 million for July 2019 and [...]
Cocrystal Pharma Announces Abstract Accepted for Oral Presentation at the ISIRV: Options X for the Control of Influenza Conference
21/08/2019
BOTHELL, WA, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today [...]
Fear of Rejection is Transplant Patient’s Top Concern
21/08/2019
CareDx partnership with American Association of Kidney Patients yields key patient insights BRISBANE, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused [...]
BioCardia Reports 2019 Second Quarter Financial Results and Business Highlights
21/08/2019
SAN CARLOS, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results [...]
HempAmericana Launches North American CBD Sales Force Following Successful Inventory Build
21/08/2019
NEW YORK, Aug. 21, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”), an emerging leader in the CBD products market, is very excited to announce the launch of [...]
CURE Pharmaceutical [OTCQB: CURR] Takes First Step To Secure Hemp CBD Supply Chain by Partnering with Fytiko Farms
21/08/2019
OXNARD, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has signed a deal with Oklahoma-based hemp grower Fytiko Farms. [...]
Altimmune Announces $3.7 Million in Additional BARDA Funding to Advance NasoShield™ Clinical Development
21/08/2019
Phase 1b clinical trial will study effect of dosing methodology on immune response to intranasal anthrax vaccine GAITHERSBURG, Md., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage [...]
Cara Therapeutics Enters into Commercial License Agreement with Enteris BioPharma, Inc. for Peptelligence® Oral Formulation Technology
21/08/2019
Peptelligence® technology currently used in Oral KORSUVA™ formulation STAMFORD, Conn., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and [...]
Pluristem Therapeutics to Host Key Opinion Leader Call on its Acute Radiation Syndrome and Hematological Deficiencies Programs
21/08/2019
HAIFA, Israel, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced that [...]

Pages